SCHEMBL30350085

CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.71

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.65

▸	NPY4R	P50391	8/20	0.65

▸	NPY5R	Q15761	8/20	0.65

▸	NPY1R	P25929	6/20	0.65

▸	EP300	Q09472	1/20	0.59

▸	HIF1A	Q16665	1/20	0.59

▸	TFPI	P10646	4/20	0.59

▸	CALCR	P30988	4/20	0.57

▸	KDM1A	O60341	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30350078	0.91	OPRD1 (0.61)	CALCR
SCHEMBL30495647	0.90	NPY2R (0.77)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30607363	0.90	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30495694	0.89	CALCR (0.63)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31020752	0.88	NPY2R (0.64)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL29805442	0.88	NPY2R (0.63)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30607435	0.88	NPY2R (0.76)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30432186	0.88	NPY2R (0.69)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31694500	0.87	NPY2R (0.66)	NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL31651397	0.87	NPY2R (0.71)	NPY2RNPY4RNPY5RNPY1RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
CN-115925960-A	Antibody or antigen binding fragment capable of being specifically bound with creatine kinase isoenzyme and application thereof	杭州傲锐生物医药科技有限公司	2023-04-07	—	—	CN	disclosed